Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1497-1504

  Shimoyama, Shouji ^a,b   Konishi, Toshiro ^b   Kawahara, Masaki ^a,b   Aoki, Fumio ^a   Harada, Nobuhiko ^c   Shimizu, Seiichiro ^b   Murakami, Toshikazu ^a   Kaminishi, Michio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Showa General Hospital   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell cycle arrest; Chemoradiation therapy; Chemoradiosensitivity; Esophageal cancer; p21(waf1 cip1); p53

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; PHENOTYPE; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031736942     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828.
2. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
3. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent LM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
4. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-704.
5. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou Z-Q: Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res 1993;53:1889-1894.
6. Bennet WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu S, Kusters I, Resau JH, Trump BF, Lae DP, Harris CC: p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992;52:6092-6097.
7. Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M: Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. Br J Cancer 1997;76:480-485.
8. Valassiadou K, Stefanaki K, Tzardi M, Datseris G, Georgoulias V, Melissas J, Tsiftsis DD, Delides G, Kanavaros P: Immunohistochemical expression of p53, bcl-2, mdm2, and waf1/p21 proteins in colorectal adenocarcinoma. Anticancer Res 1997;17:2571-2576.
9. Jiang M, Shao Z -M, Wu J, Lu J -S, Yu L -M, Yuan J -D, Han Q -X, Shen Z -Z, Fontana JA: p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer 1997;74:529-534.
10. Harada N, Gansauge S, Gansauge F, Gause H, Shimoyama S, Imaizumi T, Mattfeld T, Shoenberg MH, Beger HG: Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in pancreatic cancer. Br J Cancer 1997;76:299-305.
11. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F: Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res 1996;56:556-562.
12. El-Deiry W, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174.
13. Namba H, Hara T, Tukazaki T, Migita K, Ishikawa N, Ito K, Nagataki S, Yamashita S: Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/CIP1 pathway in human thyroid cells. Cancer Res 1995;55:2075-2080.
14. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
15. Hamada M, Fujiwara T, Hizuta A, Gochi A, Naomoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N, Orita K: The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin Oncol 1996;122:360-365.
16. Moreira LF, Naomoto Y, Hamada M, Kamikawa Y, Orita K: Assessment of apoptosis in oesophageal preoperatively treated by chemotherapy and radiotherapy. Anticancer Res 1995;15:639-644.
17. Sakakura C, Koide K, Ichikawa D, Wasaka T, Shirasu M, Kimura A, Taniguchi H, Hagiwara A, Yamaguchi T, Inazawa J, Abe T, Takahashi T, Otsuji E: Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers. Br J Cancer 1998;77:159-166.
18. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepato-Gastroenterology 1994;41:391-393.
19. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS, Padmanabahn A: Radiotherapy alone and chemoradiation for non-metastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989;63:2397-2403.
20. Shimoyama S, Konishi T, Kawahara M, Hojo K, Takeda Y, Nagayama T: Complete response of esophageal cancer achieved by combination therapy with 5-fluorouracil, low dose cisplatin, and radiation: Report of a case. Surgery Today (in press).
21. Shimoyama S, Konishi T, Kawahara M, Itoh A, Takeda Y, Hojo K: An effective combination therapy with 5-fluorouracil, low dose cisplatin, and radiation for treatment of advanced esophageal squamous cell cancer. Proc ASCO 1998;17:302a.
22. Shimoyama S, Kojima J, Kaminishi M: A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy. Hepato-Gastroenterology, in press.
23. Clayman GL, El-Naggar AK, Merritt J, Bruso P, Royj JA, Lippman S, Hong WK, Goepfert H: Adenovirus-mediated p53 gene transfer in a phase I trial of patients with advanced recurrent head and neck squamous carcinoma. Proc ASCO 1997;16:383a.
24. Beahrs OH, Henson DE, Hutter RVP, Myers MH: Manual for staging of cancer. 3rd ed. pp. 63-65 (1988). JB Lippincott, Philadelphia.
25. Finlay CA, Hinds PW, Tan T -H, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half life. Mol Cell Biol 1988;8:531-539.
26. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D -L, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 1994;84:3781-3784.
27. Michicli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-3395.
28. Isaacs JS, Chiao C, Merrick BA, Selkirk JK, Barrett JC, Weissman BE: p53-dependent p21 induction following y-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res 1997;57:2986-2992.
29. Yang G , Zhang Z, Liao J, Seril D, Wang L, Goldstein S, Yang CS: Immunohistochemical studies on Waf1p21, p16, pRb, and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int J Cancer 1997;72:746-751.
30. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, Kaye SB: Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 1993;55:678-684.
31. WAF1/CIP1 gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. Biochem Biophys Res Comm 1997;233:329-335.
32. Wouters BG, Giaccia AJ, Denko NC, Brown JM: Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 1997;57:4703-4706.
33. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-852.